-
Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
13 Jan 2025 15:16 GMT
… the first 50 TIMI trials. The Baim institute was … Journal of Medicine) and have led 70 FDA submissions from … in international approval of drugs like prasugrel, rivaroxaban, betrixaban and … which improves the way active pharmaceutical ingredients (APIs) enter …
-
Blood clot drug taken by millions of Americans may cause deaths from strokes, heart attack
13 Dec 2024 13:20 GMT
… when someone comes to the doctor after a previous heart or … and prasugrel, in a phase 3 trial.
After phase 3, the drug gets … the results from the American trials had to do with … aspirin dosing.
Thomas Marciniak, an FDA medical officer who reviewed this second …
-
New Investigation Casts Doubt on Landmark Ticagrelor Trial
13 Dec 2024 10:04 GMT
… the landmark trial that launched the antiplatelet drug ticagrelor worldwide … by some FDA staff members, including medical officer Thomas … such as clopidogrel and prasugrel.
"Critics said … readjudicating in the current treatment era."
Other calls …
-
Doubts over landmark heart drug trial: ticagrelor PLATO study
12 Dec 2024 01:27 GMT
… established in the treatment of acute coronary … like clopidogrel and prasugrel. While AstraZeneca, … FDA medical officer with an atypical reputation for thorough reviews of drug … trial “has no reason to be challenged,” but argues that subsequent trials …
-
Prasugrel Outperforms Ticagrelor in Reducing Mortality and Stroke in Routine Acute Coronary Syndrome Care: JAMA
10 Dec 2024 07:54 GMT
… with ACS undergoing invasive treatment, ticagrelor, and prasugrel are guideline-recommended … ISAR-REACT5 randomized clinical trial demonstrating prasugrel's superiority. … effectiveness of prasugrel observed in prior randomized clinical trials like ISAR …
-
Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral Hemorrhage
05 Dec 2024 14:43 GMT
… as aspirin, clopidogrel, prasugrel, ticagrelor, or dipyridamole, … medication use (separate variables for drugs with antihypertensive effects, statins, nonsteroidal anti-inflammatory drugs … , et al. Antithrombotic treatment prior to intracerebral hemorrhage: …
-
Prasugrel Bests Ticagrelor in Acute Coronary Syndrome Care
03 Dec 2024 10:58 GMT
… the two treatment groups.
In the STEMI subgroup, prasugrel was … unstable angina subgroups, both drugs showed comparable efficacy.
IN … by data from other trials,” the authors of the … from various institutions and pharmaceutical companies outside the submitted …
-
U.S. P2Y12 Inhibitors Market Projected To Witness Substantial Growth, 2024-2031: Teva Pharmaceuticals USA, Cipla, Biocon
14 Nov 2024 10:13 GMT
…
◘ Teva Pharmaceuticals USA Inc.
◘ AstraZeneca
◘ Genentech
◘ Eli Lilly and Company
… , product launch, product trials pipelines, product approvals, patents … Segmentation:
By Drug: Clopidogrel, Ticlopidine, Ticagrelor, Prasugrel, Cangrelor, Others …
-
SMT announces completion of patient enrolment for Tuxedo 2 clinical trial in India
16 Aug 2024 09:47 GMT
… trial aims to evaluate the efficacy and safety of Supraflex Cruz Drug … trial is designed to challenge existing paradigms in the treatment … disease. In addition, Prasugrel determination be compared with … Bangalore, Prof of Medicine, New York university School …
-
SMT announces completion of patient enrolment for Tuxedo-2 trial
16 Aug 2024 08:11 GMT
Sahajanand Medical Technologies (SMT) … trial aims to evaluate the efficacy and safety of Supraflex Cruz Drug … trial is designed to challenge existing paradigms in the treatment … antiplatelet therapies (Ticagrelor vs. Prasugrel).
Innovation: Utilising SMT’s …